| Literature DB >> 31758758 |
Sylvie Cossette1,2, José Côté2,3,4, Geneviève Rouleau3,4,5, Marie Robitaille1, Sonia Heppell2,6, Tanya Mailhot1,2, Guillaume Fontaine1,2, Catherine Cournoyer1, Marie-Pierre Gagnon5, Maria-Cecilia Gallani5, Jean-Francois Tanguay1,7, Jocelyn Dupuis1,7, Anil Nigam1, Marie-Claude Guertin8.
Abstract
BACKGROUND: Illness management after an acute coronary syndrome (ACS) is crucial to prevent cardiac complications, to foster participation in a cardiac rehabilitation (CR) program, and to optimize recovery. Web-based tailored interventions have the potential to provide individualized information and counseling to optimize patient's illness management after hospital discharge.Entities:
Keywords: acute coronary syndrome; health behavior; nursing informatics; pilot study; self-care
Year: 2017 PMID: 31758758 PMCID: PMC6834220 DOI: 10.2196/cardio.7342
Source DB: PubMed Journal: JMIR Cardio ISSN: 2561-1011
Figure 1TAVIE@COEUR homepage and virtual nurse (in French).
General overview of the content of TAVIE@COEUR.
| Sessions and general theme | Number of Web pages | Number of videos | Number of PDF documents | |
| Home page | 1 | 1 | 0 | |
| 17 | 14 | 35 | ||
| Session 1 objectives | 1 | 1 | 0 | |
| Taking your medication | 3 | 3 | 0 | |
| Identifying or finding out about your medication | 2 | 0 | 0 | |
| Getting motivated to take your medication | 1 | 1 | 3 | |
| Associating a positive image to your medication | 3 | 3 | 0 | |
| Observing your own behavior | 1 | 2 | 0 | |
| Identifying adverse effects or discomfort | 1 | 1 | 2 | |
| Managing adverse effects or discomfort | 2 | 0 | 19 | |
| Documenting adverse effects or discomfort | 1 | 1 | 2 | |
| Tips to avoid adverse effects or discomfort | 1 | 1 | 0 | |
| Integrating strategies for medication-taking | 1 | 1 | 9 | |
| 31 | 28 | 7 | ||
| Session 2 objectives | 1 | 1 | 0 | |
| Assessing the efficacy of advice | 1 | 0 | 0 | |
| Managing adverse effects or discomfort | 4 | 2 | 0 | |
| Associating a positive image to your medication | 6 | 5 | 0 | |
| Observing your own behavior | 3 | 2 | 0 | |
| Managing challenges in medication-taking | 3 | 5 | 0 | |
| Recognizing and changing negative thoughts | 2 | 4 | 1 | |
| The DECIDEaapproach | 6 | 8 | 4 | |
| Identifying or finding out about your medication | 2 | 0 | 0 | |
| Managing adverse effects or discomfort | 2 | 0 | 0 | |
| Documenting adverse effects or discomfort | 1 | 1 | 2 | |
| 41 | 42 | 5 | ||
| Session 3 objectives | 2 | 2 | 0 | |
| Associating a positive image to your medication | 9 | 7 | 0 | |
| Observing your own behavior | 6 | 4 | 0 | |
| Managing negative feelings | 6 | 7 | 0 | |
| The DECIDE approach | 1 | 1 | 0 | |
| Recognizing the importance of support | 2 | 2 | 1 | |
| Listening and communication skills | 3 | 3 | 1 | |
| Resources, services, and health professionals | 3 | 12 | 2 | |
| Practicing the session strategies | 2 | 1 | 1 | |
| Managing adverse effects or discomfort | 4 | 2 | 0 | |
| Identifying or finding out about your medication | 2 | 0 | 0 | |
| Documenting adverse effects or discomfort | 1 | 1 | 0 | |
| Total | 90 | 85 | 47 | |
aDECIDE is an acronym designed for helping patients solve problems. D=Describe the situation in which the oversight occurred to identify your difficulty; E=Express a list of possible strategies to address this challenge; C=Choose the strategy that is most likely to be effective and with which you feel comfortable; I=Imagine yourself using this strategy; D=Decide to take action and face the situation by putting this strategy into practice; E=Evaluate results and resume problem-solving skills when you are not satisfied with the results.
Figure 2Example of specific information provided regarding the medication of each patient (generic and commercial names, indications and tips - in French).
Participants’ baseline sociodemographic and clinical data (N=30).
| Characteristic | n (%) | |
| Sex (male) | 26 (87) | |
| Place of birth (Canada) | 24 (80) | |
| Living situation (with a partner) | 23 (77) | |
| Employment status (employed) | 16 (53) | |
| Education (high school or higher) | 15 (50) | |
| Medical antecedents (≥1) | 20 (67) | |
| Cardiovascular antecedents (≥1) | 11 (37) | |
| Myocardial infarction (STEMI) | 18 (60) | |
| Myocardial infarction (NSTEMI) | 7 (23) | |
| Unstable angina pectoris | 5 (17) | |
| Alcohol use | 19 (63) | |
| Hypertension | 16 (53) | |
| Hypercholesterolemia | 15 (50) | |
| Physical inactivity | 15 (50) | |
| Stress | 15 (50) | |
| Family history of cardiovascular disease | 14 (47) | |
| Smoking | 13 (43) | |
| Obesity | 10 (33) | |
Feasibility of TAVIE@COEUR (N=30).
| Feasibility outcomes | Mean (SDa) or n (%) | |
| Participants who began the session, n (%) | 30 (100) | |
| Participants who completed the session, n (%) | 20 (67) | |
| Mean duration of session if completed, in minutes, mean (SD) | 25 (9) | |
| Participants who began the session, n (%) | 17 (57) | |
| Participants who completed the session, n (%) | 10 (33) | |
| Mean duration of session if completed, in minutes, mean (SD) | 16 (7) | |
| Participants who began the session, n (%) | 10 (33) | |
| Participants who completed the session, n (%) | 5 (17) | |
| Mean duration of session if completed, in minutes, mean (SD) | 16 (5) | |
aSD: standard deviation.
TAVIE@COEUR acceptability (n=26).
| Outcome variable | Number of items | Possible range | Standardized mean (SDa) score after session 1 | Standardized mean (SD) score after sessions 2, session 3 or both |
| Ease of navigation | 2 | 0-4 | 3.35 (0.74) | 3.58 (0.70) |
| Ease of understanding | 2 | 0-4 | 3.43 (0.78) | 3.46 (0.63) |
| Credibility of the information | 1 | 0-4 | 2.91 (0.92) | 3.27 (0.70) |
| Tailoring of the information | 4 | 0-4 | 3.26 (0.57) | 2.93 (0.68) |
| Individual relevance | 4 | 0-4 | 2.97 (0.73) | 2.56 (0.96) |
| Applicability | 1 | 0-4 | 3.09 (0.87) | 3.55 (0.74) |
| Appreciation of user interface | 5 | 0-4 | 2.94 (0.67) | 3.04 (0.74) |
| General appreciation | 2 | 0-4 | 3.27 (0.72) | 3.24 (0.87) |
| General satisfaction score | 21 | 0-4 | 3.14 (0.57) | 3.02 (0.61) |
aSD: standard deviation.
TAVIE@COEUR preliminary effect.
| Outcome variable | Number of items | Possible range | Mean (SDa) score at baseline (n=30) | Mean (SD) score or n (%) at 1 month (n=27) | |
| 12 | 0-60 | 49.09 (6.92) | 54.07 (3.99) | ||
| Self-care related to medication-taking | 3 | 0-15 | 11.35 (2.41) | 13.74 (1.32) | |
| Self-care related to recognizing and managing symptoms | 4 | 0-20 | 15.69 (3.49) | 16.86 (2.36) | |
| Self-care related to managing changes in health condition | 3 | 0-15 | 13.24 (2.29) | 14.19 (1.47) | |
| Medication adherence (no omission), n (%) | NA | NA | NA | 14 (52) | |
| Anxiety | 20 | 20-80 | NA | 33.36 (12.28) | |
| Cardiac risk factors | 25 | 0-144 | NA | 83.96 (11.25) | |
| Enrollment in cardiac rehabilitation, n (%) | NA | NA | NA | 12 (40) | |
aSD: standard deviation.